… plus spacer device was compared with a dry-powder inhaler for … with asthma or chronic
obstructive pulmonary disease. … with terbutaline, the use of a pear-shaped spacer significantly …

… During the experiment, 5mg terbutaline was administered, and the loss of inhaled dose …
positive expiratory pressure (PEP) [47]. ere are no consistent data on NIV in CF with respiratory …

… expiratory pressures of 20 and 5 cm H 2 O, 1:3 inspiratory–… significant difference was found
between the three spacers … Aerodynamic characteristics of nebulized terbutaline sulphate …

… as between the spacers was equivalent. However, the USAL0.5 of the MDI was not
bioequivalent to spacers (20 and 18 µg) despite being equivalent between the spacers. In contrast, …

… that for chronic obstructive pulmonary disease (COPD) patients, … is a new double cone shaped
large spacer with internal volume … on the inhalation filter could be a result of spacer larger …

… be described in this thesis, may not be owned by the author and … and must not be made
available for use without the prior … However, in patients with chronic bronchitis, this volume can …

… with an asthma spacer or as a dry powder inhaler. The … , and chronic bronchitis is a description
of symptoms that may or may … β2 agonists available include salbutamol and terbutaline. …

… such as asthma, chronic obstructive pulmonary disease, and diabetes. … -dose inhaler,
nebulizer, and dry powder inhaler that are … of bronchiole walls without obvious fibrosis. Alongside …

… not use their pressurized metered dose inhaler correctly, while 50-60% misuse a dry powder
inhaler… Obstructive Pulmonary Disease patients being discharged from hospital. Adherence …

… aerosolized inhalation therapy for such respiratory diseases. … However, the inhalation profile
which is an important factor has not … of the drug more distally with a cone front laminar flow. …